VLA-4/VCAM-1 inhibitors (Princeton University)

N/A

Report date: 2025/03/20 09:26:23

Base Information

Drug NameVLA-4/VCAM-1 inhibitors (Princeton University)
Drug Alias Namevery late antigen-4/vascular cell adhesion molecule-1 inhibitors (Princeton University)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIntegrin alpha-4 inhibitorsVascular cell adhesion molecule 1 inhibitors
TargetsVascular cell adhesion molecule 1Integrin alpha-4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrinceton University
China Registration ClassN/A

Develop Information

Active CompaniesPrinceton University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A